Fresenius announces HY bond
The tally of corporate bond roadshows in Europe continues to rise, but more significant still is that Fresenius Medical Care has declared it wants to sell €400m and $300m of high yield bonds.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts